SCHEMBL6652833

SCHEMBL6652833

CCc1ccc(CCN2CC=C(c3cccc(C(F)(F)F)c3)CC2)cc1CC(C)C

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.53
PPARA Q07869 6/20 0.53
HTR7 P34969 2/20 0.46
PARP1 P09874 5/20 0.42
HTR1A P08908 3/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
CCR2 P41597 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
GAA P10253 1/20 0.37
KCNA3 P22001 1/20 0.37
HTR2C P28335 1/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6653822 0.96 PPARG (0.53) PPARGPPARAHTR7PARP1HTR1A
SCHEMBL4589358 0.95 PPARG (0.51) PPARGPPARAHTR7PARP1HTR1A
SCHEMBL4588233 0.93 PPARG (0.53) PPARGPPARAHTR7PARP1HTR1A
Hydrochloric Acid SCHEMBL4587862 0.92 PPARG (0.53) PPARGPPARAHTR7PARP1HTR1A
SCHEMBL6543177 0.90 PPARG (0.50) PPARGPPARAHTR7PARP1HTR1A
SCHEMBL6543200 0.90 PPARG (0.50) PPARGPPARAHTR7PARP1HTR1A
SCHEMBL6543261 0.90 PPARG (0.51) PPARGPPARAHTR7PARP1HTR1A
SCHEMBL6543266 0.88 PPARG (0.51) PPARGPPARAHTR7PARP1HTR1A
SCHEMBL4588196 0.88 PPARG (0.56) PPARGPPARAHTR7PARP1KDM4E
SCHEMBL6543482 0.87 PPARG (0.52) PPARGPPARAHTR7PARP1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979079-B1 USE OF TETRAHYDROPYRIDINE DERIVATIVES TO PREPARE MEDICINES FOR TREATING DISEASES CAUSING DEMYELINATION SANOFI SYNTHELABO (FR) 2004-06-16 EP disclosed
EP-1017385-B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 SANOFI SYNTHELABO (FR) 2003-07-16 EP disclosed
EP-0950048-B1 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES FOR TREATING ALZHEIMER'S DISEASE SANOFI SYNTHELABO (FR) 2001-06-27 EP disclosed
EP-0979079-A1 USE OF TETRAHYDROPYRIDINE DERIVATIVES TO PREPARE MEDICINES FOR TREATING DISEASES CAUSING DEMYELINATION SANOFI-SYNTHELABO (FR) 2000-02-16 EP disclosed
WO-1998048802-A1 USE OF TETRAHYDROPYRIDINE DERIVATIVES TO PREPARE MEDICINES FOR TREATING DISEASES CAUSING DEMYELINATION SANOFI-SYNTHELABO (FR) 1998-11-05 WO disclosed